Inhibition of cardiomyocyte-specific TF or thrombin attenuates myocardial injury and inflammation (12), but the underlying mechanisms linking coagulation proteases to immune cell activation and outcomes after MI remain unclear. This evidence concerns the gene TF and myocardial infarction.